During the past decade, SEC Clinical Research conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "SEC Clinical Research" #1 collaborator was "Iqvia Pty Ltd" with 1 trials as a collaborator, "Syneos Health" with 1 trials as a collaborator and "bioRASI, LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "SEC Clinical Research" are "Hot Flashes" (2 trials), "Chronic Obstructive Pulmonary Disease" (1 trials) and "Idiopathic Pulmonary Fibrosis (IPF)" (1 trials). Many other conditions were trialed in "SEC Clinical Research" in a lesser frequency.

Most popular intervention types in "SEC Clinical Research" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "fezolinetant" (2 trials), "placebo" (2 trials), "Ensifentrine" (1 trials) and "GB0139" (1 trials). Other intervention names were less common.

The vast majority of trials in "SEC Clinical Research" are 2 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "SEC Clinical Research". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in SEC Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SEC Clinical Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".